Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C
- 13 March 2014
- journal article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 46 (5) , 440-445
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCCJournal of Hepatology, 2011
- Boceprevir for Previously Treated Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2011
- Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirinClinical and Molecular Hepatology, 2011
- Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infectionHepatology, 2010
- High prevalence of late relapse and reinfection in prisoners treated for chronic hepatitis CJournal of Gastroenterology and Hepatology, 2010
- Antiviral Treatment of Recurrent Hepatitis C After Liver Transplantation: Predictors of Response and Long-Term OutcomeTransplantation, 2009
- Global epidemiology of hepatitis C virus infectionThe Lancet Infectious Diseases, 2005
- Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combinationJournal of Hepatology, 2004
- High Incidence of Allograft Cirrhosis in Hepatitis C Virus Genotype 1B Infection Following Transplantation: Relationship With Rejection EpisodesHepatology, 1999
- Quantitation of hepatitis C viral RNA in liver and serum samples using competitive polymerase chain reaction.Journal of Clinical Pathology, 1995